NCI Official Says Public Health Issue As Important As Data In Mammography
In Brief: extramural Affairs Director Diggs to Leave NIH; Bonadonna, Fisher Share Bristol-Meyer Award
Generic Drug Makers Set Sights In Taxol Worldwide Market
Tamoxfin Trial accrues 6,000, Problems with Minority accrual Remain
White House Order Poses Difficulties For NIH Peer Review
NCI Cancer Education Program To Open To Innovative Ideas
NCI To Hold Symposium To Honor Wener Kirsten
AACR honors Five With Awards Next Month
Trending Stories
- An opportunity for Trump: Position U.S. cancer science to lead the world
- Former Maryland Governor Larry Hogan to receive Public Service Leadership Award from National Coalition for Cancer Survivorship
- The Directors: Tom Lynch and Skip Burris on how NIH funding cuts imperil biopharma innovation—and cost patient lives
In a time of uncertainty, “react to the knowns, not the fear” - Grilled by Congress, Kennedy defends NIH and NCI budget cuts, freezes, and RIFs
To avoid “offending” pharma, NCI doesn’t study the causes of early-onset colon cancer, HHS secretary incorrectly alleges - NIH eliminates the NCI Board of Scientific Advisors
Over its 28 year history, BSA shaped NCI-funded extramural science - Kennedy’s claims notwithstanding, NCI clinical trials are delayed, enrollments reduced
NCI’s Steven A. Rosenberg: “Almost all patients are getting delayed by about a month, but then again, we’re turning away more patients.”
